HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Skyn Iceland Yanks Micellar Cleansing Water For Microbial Issue; Henkel Mislabels Skin-Care Items; More Recall News

Executive Summary

The same gram-negative bacillus cited in Skyn Iceland’s ongoing recall was detected in lots of La Bella Extreme Sport Styling Gel from the Eden Prairie, Minn.-based Village Company, prompting voluntary action to remove it from circulation. Recent FDA enforcement reports also highlight recalls from Young Living and Henkel for contamination and labeling issues, respectively.

You may also be interested in...



More Asbestos-Linked Makeup Recalls Ring Regulatory Legislation Bell Again

Claire’s Stores Inc. voluntarily recalled one lot of JoJo Siwa Makeup Set and private-label manufacturer Beauty Plus Global Inc. recalled one lot of Contour Effects Palette 2. House Energy and Commerce Committee Chairman Frank Pallone says it is “unacceptable” for FDA to rely on voluntary recalls and he is working on legislation that would overhaul cosmetics regulations and give agency mandatory recall authority.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149036

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel